Fig. 6

Evaluation of PSMA expression in TNBC tumors using [¹⁷⁷Lu]Lu-PSMA-I&T AURA (A–C; zoom-in: D–F) with corresponding H&E staining (G–I); and [¹⁷⁷Lu]Lu-PSMA-I&T mAURA (J–L) with corresponding PSMA/CD31 immunofluorescence staining analysis (M–R). Scale bars: A–C & G–I: 4 mm, J–L: 20 µm; M–O: 50 µm; P–R: 100 µm